Recent

% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • ccharles792 ccharles792 Dec 11, 2012 12:38 AM Flag

    James Stocklaser Who said BUY ACAD, Now Says CELG is STRONG BUY. ((link))

    Seeking: James Stocklaser Who said BUY ACAD, Now Says CELG is STRONG BUY. ((link))
    A Reasoned Case For Celsion's ThermoDox
    December 10, 2012 BY:
    James Stocklasar Thomas Jr
    I think it's common knowledge that any therapy that promotes progression free recurrence is a global billion dollar plus market opportunity. As others have pointed out, with ThermoDox targeting multiple medical indications, the long-term market opportunity is a billion dollar multiple. Seeing how Celsion has already extended the ThermoDox footprint into the European and Asia markets along with the rest of the world including the United States, I hesitate to imagine how high on phase III success the company's share price could rise as events unfold. Therefore, priced in the $7's/share and taking every risk into account, I conclude based on my three-prong study that Celsion is a VERY STRONG BUY.

 
ARNA
1.81+0.08(+4.62%)Sep 27 4:00 PMEDT